GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Sale Of Business

Kindstar Globalgene Technology (HKSE:09960) Sale Of Business : HK$0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Sale Of Business?

Kindstar Globalgene Technology's sale of business for the six months ended in Jun. 2024 was HK$0 Mil. It means Kindstar Globalgene Technology gained HK$0 Mil from selling business. Kindstar Globalgene Technology's sale of business for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0 Mil.

Compared with last quarter (HK$0 Mil in Dec. 2023 ), Kindstar Globalgene Technology gained the same money from selling business in Jun. 2024 (HK$0 Mil).


Kindstar Globalgene Technology Sale Of Business Historical Data

The historical data trend for Kindstar Globalgene Technology's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Sale Of Business Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial - 0.97 - - -

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - 1.04 - -

Kindstar Globalgene Technology Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindstar Globalgene Technology Sale Of Business Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.
Executives
Cpechina Fund Iii, L.p. 2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited 2101 Beneficial owner
Cpe Funds Iii Limited 2201 Interest of corporation controlled by you
Cpe Holdings International Limited 2201 Interest of corporation controlled by you
Cpe Holdings Limited 2201 Interest of corporation controlled by you
Huang Shiang 2101 Beneficial owner
Tu Zanbing
Huang Zuie-chin 2101 Beneficial owner
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Jackson Hole Trust Company
Huang Bo
Kernelstar Limited 2301 Trustee
Kastle Limited 2301 Trustee
Guo Gui-rong 2202 Interest of your spouse
Morningside Holdings (asia) Limited 2201 Interest of corporation controlled by you

Kindstar Globalgene Technology Headlines

No Headlines